Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors.
作者信息
Sehgal Kartik
机构信息
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA Netw Open. 2021 Mar 1;4(3):e211839. doi: 10.1001/jamanetworkopen.2021.1839.
Abstract
摘要
Zotero 插件